| Literature DB >> 35095799 |
Bálint József Nagy1,2, Bence Balázs1,2, Isma Benmazouz1,3, Péter Gyüre3, László Kövér3, Eszter Kaszab4, Krisztina Bali4, Ádám Lovas-Kiss5, Ivelina Damjanova6, László Majoros1, Ákos Tóth6, Krisztián Bányai4,7, Gábor Kardos1,7.
Abstract
During winter, a large number of rooks gather and defecate at the park of a university clinic. We investigated the prevalence of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in these birds and compared recovered isolates with contemporary human isolates. In 2016, fecal samples were collected from 112 trap-captured rooks and investigated for presence of ESBL producers using eosin methylene blue agar supplemented by 2 mg/L cefotaxime; 2,455 contemporary human fecal samples of patients of the clinics sent for routine culturing were tested similarly. In addition, 42 ESBL-producing E. coli isolates collected during the same period from inpatients were also studied. ESBL genes were sought for by PCR and were characterized by sequencing; E. coli ST131 clones were identified. Epidemiological relatedness was determined by pulsed-field gel electrophoresis and confirmed using whole genome sequencing in selected cases. Thirty-seven (33%) of sampled rooks and 42 (1.7%) of human stools yielded ESBL-producing E coli. Dominant genes were bla CTX-M-55 and bla CTX-M-27 in corvid, bla CTX-M-15 and bla CTX-M-27 in human isolates. ST162 was common among rooks. Two rook-derived E. coli belonged to ST131 C1-M27, which was also predominant (10/42) among human fecal and (15/42) human clinical isolates. Another potential link between rooks and humans was a single ST744 rook isolate grouped with one human fecal and three clinical isolates. Despite possible contact, genotypes shared between rooks and humans were rare. Thus, rooks are important as long-distance vectors and reservoirs of ESBL-producing E. coli rather than direct sources of infections to humans in our setting.Entities:
Keywords: CTX-M-55; E. coli ST131; E. coli ST162; E. coli ST744; ESBL carriage; bird migration; long-distance dispersal
Year: 2022 PMID: 35095799 PMCID: PMC8792927 DOI: 10.3389/fmicb.2021.785411
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Results of whole genome sequencing of the selected isolates.
| PFGE | Strain source | ST | Resistance genes | Plasmid replicons | |||||||
|
| Qui | Agl | Tri | Sul | Mac | Phe | Tet | ||||
| EC088 | 857 Clinical | 744 | gyrA p.S83L | aadA5 aph(6)-Id aph(3″)-Ib | dfrA17 | sul2 | mdf(A) | catA1 | tet(B) | IncFII IncI1-I IncQ1 | |
| 1254 Fecal | 744 | gyrA p.S83L | aadA5 aph(6)-Id aph(3″)-Ib | dfrA17 | sul1 | mdf(A) | catA1 | tet(B) | IncFII IncI1-I IncQ1 | ||
| 1418 Clinical | 744 | gyrA p.S83L | aadA5 aph(6)-Id aph(3″)-Ib | dfrA17 | sul1 | mdf(A) | catA1 | tet(B) | IncFII IncQ1 | ||
| 8544sz Rook | 744 | qnrS1 | aadA5 aph(6)-Id aph(3″)-Ib | dfrA17 | sul1 | mdf(A) | catA1 | tet(A) | IncFIA IncFIB | ||
| 42081 Clinical | 744 | gyrA p.S83L | aadA5 aph(6)-Id aph(3″)-Ib | dfrA17 | sul1 | catA1 | tet(B) | IncFII IncI1-I IncQ1 | |||
| EC378 | 8579 Rook | 24 | mdf(A) | IncFIB IncFII | |||||||
| 8550 Rook | 24 | mdf(A) | IncFIB IncFII | ||||||||
| HOR3sz Rook | 24 | mdf(A) | IncFIB | ||||||||
| EC069 | 5386 Clinical | 131 | qnrS1 | aadA5 aph(6)-Id aph(3″)-Ib | dfrA17 | sul1 | mdf(A) mph(A) | tet(A) | IncFIA IncFIB | ||
| 42532 Fecal | 131 | qnrS1 | aadA5 aph(6)-Id aph(3″)-Ib | dfrA17 | sul1 | mdf(A) | IncFIA IncFIB IncFII | ||||
| 8578sz Rook | 131 | gyrA p.S83L | aadA5 aph(6)-Id aph(3″)-Ib | dfrA17 | sul1 | mdf(A) mph(A) | tet(A) | Col156 IncFIA IncFIB | |||
| 2647 Fecal | 69 | gyrA p.S83L | dfrA14 | erm(B) mdf(A) mph(A) | tet(B) | Col156 IncFIA IncFIB | |||||
| 8546 Rook | 131 | gyrA p.S83L | aadA5 aph(6)-Id aph(3″)-Ib | dfrA17 | sul1 | mdf(A) mph(A) | tet(A) | Col156 IncFIA IncFIB IncFII | |||
| EC183 | 40242k Fecal | 131 | gyrA p.S83L | aadA5 aph(6)-Id aph(3″)-Ib | dfrA17 | sul1 | mdf(A) mph(A) | tet(A) | Col156 IncFIB IncFII | ||
| 8563 Rook | 162 | sul2 | mdf(A) | tet(A) | IncFIB | ||||||
| EC399 | 2909 Fecal | 23 | mdf(A) | IncFIB IncFIC IncI1-I | |||||||
| EC382 | 8523 Rook | 162 | qnrS1 | aph(6)-Id aph(3″)-Ib | dfrA7 | sul1 sul2 | mdf(A) | tet(A) | IncN lncQ1 | ||
| 8583F Rook | 162 | qnrS1 | aph(6)-Id aph(3″)-Ib | dfrA7 | sul1 sul2 | mdf(A) | tet(A) | IncN lncQ1 | |||
| HOR3F Rook | 162 | qnrS1 | aph(6)-Id aph(3″)-Ib | dfrA7 | sul1 sul2 | mdf(A) | tet(A) | IncN lncQ1 | |||
| 8551F Rook | 162 | qnrS1 | aph(6)-Id aph(3″)-Ib | dfrA7 | sul1 sul2 | mdf(A) | tet(A) | IncN lncQ1 | |||
Bl, beta-lactam; Fq, fluoroquinolone; Agl, aminoglycoside; Tri, trimethoprim; Sul, sulfonamide; Mac, macrolide; Phe, phenicol; Tet, tetracycline.
FIGURE 1Minimum spanning tree based on cgMLST allelic profiles of 20 sequenced E. coli isolates. Each circle represents an allelic profile based on sequence analysis of 2,513 cgMLST target genes. The numbers on the connecting lines illustrate the numbers of target genes with different alleles. Closely related genotypes (<10 alleles difference) are shaded.